trending Market Intelligence /marketintelligence/en/news-insights/trending/i62dmqygu1wpvpormvzldq2 content esgSubNav
In This List

TRACON Pharmaceuticals chief business officer to resign

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


TRACON Pharmaceuticals chief business officer to resign

H. Casey Logan plans to resign as chief business officer of TRACON Pharmaceuticals Inc., effective March 2, to pursue a new professional opportunity.

Logan's resignation is not a result of any disagreement with the company.